Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PulseMedica has generated promising initial results from preclinical and early clinical studies with its image-guided laser platform for treating eye floaters. The company is advancing toward first-in-human clinical trials and regulatory approval, supported by recent funding rounds. Their approach aims to offer a safer, non-invasive alternative to traditional surgical or injection-based treatments for vitreoretinal diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PulseMedica.